Evidence map›Paper›PMID 35887562›Full record

ArticleJournal of personalized medicine2022

A Proposed Personalized Spine Care Protocol (SpineScreen) to Treat Visualized Pain Generators: An Illustrative Study Comparing Clinical Outcomes and Postoperative Reoperations between Targeted Endoscopic Lumbar Decompression Surgery, Minimally Invasive TLIF and Open Laminectomy.

Kai-Uwe Lewandrowski, Ivo Abraham, Jorge Felipe Ramírez León, Albert E Telfeian, Morgan P Lorio, Stefan Hellinger, Martin Knight, Paulo Sérgio Teixeira De Carvalho, Max Rogério Freitas Ramos, Álvaro Dowling and 6 more

Open access · goldAbstract read
In one paragraph

Article in Journal of personalized medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 10 institutions in 5 countries.

Kai-Uwe LewandrowskiFundación Universitaria Sanitas, Clínica Reina Sofía-Clínica Colsanitas, Centro de Columna-Cirugía Mínima Invasiva, Bogotá 104-76, D.C., Colombia.ORCID 0000-0001-7842-2914
Ivo AbrahamPharmacy Practice and Science, Family and Community Medicine, Clinical Translational Sciences at the University of Arizona, Roy P. Drachman Hall, Rm. B306H, Tucson, AZ 85721, USA.ORCID 0000-0002-5224-4977
Jorge Felipe Ramírez LeónMinimally Invasive Spine Center Bogotá D.C. Colombia, Reina Sofía Clinic Bogotá D.C. Colombia, Department of Orthopaedics Fundación Universitaria Sanitas, Bogotá 104-76, D.C., Colombia.
Albert E TelfeianDepartment of Neurosurgery, Rhode Island Hospital, The Warren Alpert Medical School of Brown University, Providence, RI 12321, USA.
Morgan P LorioAdvanced Orthopedics, 499 East Central Parkway, Altamonte Springs, FL 32701, USA.
Stefan HellingerDepartment of Orthopedic Surgery, Arabellaklinik, 81925 Munich, Germany.
Martin KnightThe Weymouth Hospital, 42-46 Weymouth Street London, 27 Harley Street, London W1G 9QP, UK.
Paulo Sérgio Teixeira De CarvalhoPain and Spine Minimally Invasive Surgery Service at Gaffre e Guinle University Hospital, Rio de Janeiro 20270-004 RJ, Brazil.
Max Rogério Freitas RamosOrthopedic Clinics at Gaffrée Guinle University Hospital HUGG, Rio de Janeiro 20270-004 RJ, Brazil.
Álvaro DowlingOrthopaedic Spine Surgeon, Director of Endoscopic Spine Clinic, Santiago 8330024, Chile.
Manuel Rodriguez GarciaSpine Clinic, The American-Bitish Cowdray Medical Center I.A.P. Campus Santa Fe, México City 87501, Mexico.
Fauziyya MuhammadSociety for Brain Mapping and Therapeutics (SBMT), Los Angeles, CA 90272, USA.
Namath HussainSociety for Brain Mapping and Therapeutics (SBMT), Los Angeles, CA 90272, USA.
Vicky YamamotoSociety for Brain Mapping and Therapeutics (SBMT), Los Angeles, CA 90272, USA.
Babak KatebSociety for Brain Mapping and Therapeutics (SBMT), Los Angeles, CA 90272, USA.
Anthony YeungDesert Institute for Spine Care, Phoenix, AZ 85058, USA.
Brain Mapping Foundation · USDesert Institute For Spine Care · USHospital Universitário Gaffrée e Guinle · BRBrown University · USCentro Médico ABC · MXFundación Universitaria Sanitas · COLoma Linda University · USMiddle East Institute · USUniversity of Arizona · USWeymouth Community Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Endoscopically visualized spine surgery has become an essential tool that aids in identifying and treating anatomical spine pathologies that are not well demonstrated by traditional advanced imaging, including MRI. These pathologies may be visualized during endoscopic lumbar decompression (ELD) and categorized into primary pain generators (PPG). Identifying these PPGs provides crucial information for a successful outcome with ELD and forms the basis for our proposed personalized spine care protocol (SpineScreen). Methods: a prospective study of 412 patients from 7 endoscopic practices consisting of 207 (50.2%) males and 205 (49.8%) females with an average age of 63.67 years and an average follow-up of 69.27 months was performed to compare the durability of targeted ELD based on validated primary pain generators versus image-based open lumbar laminectomy, and minimally invasive lumbar transforaminal interbody fusion (TLIF) using Kaplan-Meier median survival calculations. The serial time was determined as the interval between index surgery and when patients were censored for additional interventional and surgical treatments for low back-related symptoms. A control group was recruited from patients referred for a surgical consultation but declined interventional and surgical treatment and continued on medical care. Control group patients were censored when they crossed over into any surgical or interventional treatment group. Results: of the 412 study patients, 206 underwent ELD (50.0%), 61 laminectomy (14.8%), and 78 (18.9%) TLIF. There were 67 patients in the control group (16.3% of 412 patients). The most common surgical levels were L4/5 (41.3%), L5/S1 (25.0%), and L4-S1 (16.3%). At two-year f/u, excellent and good Macnab outcomes were reported by 346 of the 412 study patients (84.0%). The VAS leg pain score reduction was 4.250 ± 1.691 (p < 0.001). No other treatment during the available follow-up was required in 60.7% (125/206) of the ELD, 39.9% (31/78) of the TLIF, and 19.7% (12/61 of the laminectomy patients. In control patients, only 15 of the 67 (22.4%) control patients continued with conservative care until final follow-up, all of which had fair and poor functional Macnab outcomes. In patients with Excellent Macnab outcomes, the median durability was 62 months in ELD, 43 in TLIF, and 31 months in laminectomy patients (p < 0.001). The overall survival time in control patients was eight months with a standard error of 0.942, a lower boundary of 6.154, and an upper boundary of 9.846 months. In patients with excellent Macnab outcomes, the median durability was 62 months in ELD, 43 in TLIF, and 31 months in laminectomy patients versus control patients at seven months (p < 0.001). The most common new-onset symptom for censoring was dysesthesia ELD (9.4%; 20/206), axial back pain in TLIF (25.6%;20/78), and recurrent pain in laminectomy (65.6%; 40/61) patients (p < 0.001). Transforaminal epidural steroid injections were tried in 11.7% (24/206) of ELD, 23.1% (18/78) of TLIF, and 36.1% (22/61) of the laminectomy patients. The secondary fusion rate among ELD patients was 8.8% (18/206). Among TLIF patients, the most common additional treatments were revision fusion (19.2%; 15/78) and multilevel rhizotomy (10.3%; 8/78). Common follow-up procedures in laminectomy patients included revision laminectomy (16.4%; 10/61), revision ELD (11.5%; 7/61), and multilevel rhizotomy (11.5%; 7/61). Control patients crossed over into ELD (13.4%), TLIF (13.4%), laminectomy (10.4%) and interventional treatment (40.3%) arms at high rates. Most control patients treated with spinal injections (55.5%) had excellent and good functional outcomes versus 40.7% with fair and poor (3.7%), respectively. The control patients (93.3%) who remained in medical management without surgery or interventional care (14/67) had the worst functional outcomes and were rated as fair and poor. Conclusions: clinical outcomes were more favorable with lumbar surgeries than with non-surgical control groups. Of the control patients, the crossover rate into interventional and surgical care was 40.3% and 37.2%, respectively. There are longer symptom-free intervals after targeted ELD than with TLIF or laminectomy. Additional intervention and surgical treatments are more often needed to manage new-onset postoperative symptoms in TLIF- and laminectomy compared to ELD patients. Few ELD patients will require fusion in the future. Considering the rising cost of surgical spine care, we offer SpineScreen as a simplified and less costly alternative to traditional image-based care models by focusing on primary pain generators rather than image-based criteria derived from the preoperative lumbar MRI scan.

Indexed as

aftercaredurabilitylumbar decompression surgerylumbar foraminal and lateral recess stenosispain generatorspostoperative natural historyreoperation

Identifiers

PMID35887562
PMCPMC9320410
OpenAlexW4283738113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.